|
PDF (176 KB) |
Back to the beginning of this Update |
The following table lists diagnosis-restricted drug categories and the corresponding diagnosis codes and disease descriptions. When a prescription is written for a diagnosis listed in this attachment, prior authorization (PA) is not required. For uses outside the listed diagnoses, PA is required. Submission of peer-reviewed medical literature to support the proven efficacy of the requested use of the drug is also required.
Note: This table includes Wisconsin Medicaid’s most current information and may be updated periodically. All drugs listed in the "Brand Name" column of this table are registered or trademarked by the manufacturer.
|
Diagnosis Code Description |
Diagnosis Code |
Generic Drug |
Brand Name |
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)-induced
gastric ulcer |
E9356
|
Omeprazole |
Prilosec OTC 20 mg tablets |
|
H. Pylori infection |
04186 |
||
|
Zollinger-Ellison syndrome |
2515 |
||
|
Erosive esophagitis |
53019 |
||
|
Gastroesophageal reflux |
53081 |
||
|
Gastric hypersecretory conditions |
5368 |
||
|
NSAID-induced gastric ulcer |
E9356 |
Lansoprazole |
Prevacid Suspension |
|
H. Pylori infection |
04186 |
||
|
Zollinger-Ellison syndrome |
2515 |
||
|
Erosive esophagitis |
53019 |
||
|
Gastroesophageal reflux |
53081 |
||
|
Gastric hypersecretory conditions |
5368 |
||
|
NSAID-induced gastric ulcer |
E9356 |
Misoprostol |
Cytotec |
|
H. Pylori infection |
04186 |
Lansoprazole/ |
Prevpac |
|
Gaucher’s Disease |
2727 |
Alglucerase |
Ceredase, Cedezyme |
|
Gaucher’s Disease |
2727 |
Miglustat |
Zavesca |
|
Anemia from Acquired Immune Deficiency Syndrome (AIDS) |
042 |
Epoetin |
Epogen, Procrit |
|
Renal failure |
585 |
||
|
Malignancy |
2399 |
||
|
Renal failure |
585 |
Darbopoetin Alfa in Albumin Solution |
Aranesp |
|
Chronic hepatitis C without hepatic coma |
07054 |
Interferon Alfa 2A |
Roferon-A |
|
Malignant melanoma |
1729 |
||
|
Kaposi’s sarcoma |
1760-1769 |
||
|
Hairy cell leukemia |
2024 |
||
|
Non-Hodgkin’s lymphoma |
2028 |
||
|
Multiple myeloma |
2030 |
||
|
Chronic myelocytic leukemia |
2051 |
||
|
Bladder carcinoma |
2337 |
||
|
Renal cell carcinoma |
2339 |
||
|
Chronic hepatitis C without hepatic coma |
07054 |
Interferon Alfa 2B |
Intron A |
|
Condylomata acuminata |
07811 |
||
|
Malignant melanoma |
1729 |
||
|
Kaposi’s sarcoma |
1760-1769 |
||
|
Hairy cell leukemia |
2024 |
||
|
Non-Hodgkin’s lymphoma |
2028 |
||
|
Multiple myeloma |
2030 |
||
|
Bladder carcinoma |
2337 |
||
|
Renal cell carcinoma |
2339 |
||
|
Chronic hepatitis C without hepatic coma |
07054 |
Peginterferon Alfa-2A |
Pegasys |
|
Chronic hepatitis C without hepatic coma |
07054 |
Peginterferon Alfa-2B |
Peg-Intron |
|
Condylomata acuminata |
07811 |
Interferon Alfa N3 |
Alferon N |
|
Chronic granulomatous disease |
2881 |
Interferon Gamma 1B |
Actimmune |
|
Osteopetrosis |
75652 |
||
|
Chronic hepatitis C without hepatic coma |
07054 |
Interferon Alfacon 1 |
Infergen |
|
Chronic hepatitis C without hepatic coma |
07054 |
Interferon Alfa 2B/Ribavirin |
Rebetron |
|
Chronic hepatitis C without hepatic coma |
07054 |
Ribavirin |
Copegus |
|
Chronic hepatitis C without hepatic coma |
07054 |
Ribavirin |
Rebetol |
|
Multiple sclerosis |
340 |
Interferon Beta 1A |
Avonex |
|
Multiple sclerosis |
340 |
Interferon Beta 1B |
Betaseron |
|
Multiple sclerosis |
340 |
Interferon Beta 1A, Albumin |
Rebif |
|
Agranulocytosis/Neutropenia |
2880 |
Filgrastim |
Neupogen |
|
Agranulocytosis/Neutropenia |
2880 |
Pegfilgrastim |
Neulasta |
|
Myeloid leukemia |
205 |
Sargramostim |
Leukine |
|
Impetigo |
684 |
Mupirocin |
Bactroban 2 percent |
|
Organ transplant rejection |
9968 |
Muromonab CD3 |
Orthoclone OKT-3 |
|
Nicotine dependence treatment |
3051 |
Bupropion |
Zyban |
|
Nicotine dependence treatment |
3051 |
Nicotine |
Prostep, Habitrol |
|
Blepharospasm |
33381 |
Botulinum Toxin Type A |
Botox |
|
Spasmodic Torticollis |
33383 |
||
|
Strabismus |
3780-37887 |
||
|
Spasmodic Torticollis |
33383 |
Botulinum Toxin Type B |
Myobloc |
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Methylphenidate |
Concerta |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
Attention Deficit Disorder with hyperactivity (ADHD) |
31401 |
||
|
Narcolepsy and Cataplexy |
347 |
||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Dexmethylphenidate |
Focalin |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Dextroamphetamines |
Dexedrine |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Narcolepsy and Cataplexy |
347 |
||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Amphetamines |
Adderall |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Narcolepsy and Cataplexy |
347 |
||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Methamphetamines |
Desoxyn |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Obesity |
278 |
||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Atomoxetine HCl |
Strattera |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Narcolepsy and Cataplexy |
347 |
Modafinil |
Provigil |
| Obstructive sleep apnea, hypopnea, and shift-work sleep disorder | 78057 | ||
|
Hyperkinetic syndrome of childhood — Attention Deficit Disorder |
314 |
Pemoline |
Cylert |
|
Attention Deficit Disorder without mention of hyperactivity |
31400 |
||
|
ADHD |
31401 |
||
|
Anemia in end-stage renal disease |
28521 |
Legend Renal Care Vitamins |
Renax |
|
Chronic renal failure |
585 |
||
|
Disorders resulting from impaired renal function |
588 |
||
|
Unspecified disorder resulting from impaired renal function |
5889 |
||
|
Normal pregnancy |
V22-V222 |
Legend Prenatal Vitamins |
|
|
High-risk pregnancy |
V23-V239 |
||
|
Lactating |
V241 |
Attachment 1: Brand Medically Necessary
Drugs That Require Prior Authorization
Attachment 2: Brand Medically Necessary
Prior Authorization Documentation
Attachment 3:
MedWatch Reporting Form (FDA Web site) (PDF, 53 KB)
Attachment 4: Specialized Transmission
Approval Technology-Prior Authorization (STAT-PA) Drugs
Attachment 5: Drug Products Requiring Paper Prior Authorization
Attachment 6: Diagnosis-Restricted Drugs (Organized by Generic Drug
Name)
Attachment 8: Covered Over-the-Counter Drugs
Attachment 9: Noncovered Drugs
Attachment 10: Age- and Gender-Restricted Drugs
Attachment 11: Covered Over-the-Counter Drugs for HealthCheck "Other
Services"
Attachment 12: Comparison of Wisconsin Medicaid and Wisconsin SeniorCare
Policies
Attachment 13: Obsolete 1/1/05: STAT-PA Drug Worksheet for Brand Name Clozaril®
— Use
Prior Authorization / Brand Medically Necessary Attachment (PA/BMNA)
(fillable PDF, 225 KB) |
Instructions (PDF, 71 KB)